DNPUFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Sumitomo Pharma Co., Ltd.

$10.15+0.00%(+$0.00)

TickerSpark Score

74/100

Solid

Valuation

100

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNPUF research report →

52-Week Range30% of range

Low $6.34

Current $10.15

High $19.20

Companywww.sumitomo-pharma.com

Sumitomo Pharma Co. , Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally.

CEO: Toru Kimura
IPO: 2012
Employees: 4,980
HQ: Osaka, JP

Price Chart

+55.44% · this period

Valuation

Market Cap: $4.55B
P/E: 5.85
P/S: 1.56
P/B: 2.14
EV/EBITDA: 12.36
Div Yield: 0.00%

Profitability

Gross Margin: 56.67%
Op Margin: 11.11%
Net Margin: 23.58%
ROE: 41.78%
ROIC: 8.81%

Growth & Income

Revenue: $456.15B · 14.37%
Net Income: $107.54B · 355.01%
EPS: $270.03 · 353.91%
Op Income: $50.66B
FCF YoY: 1846.06%

Performance & Tape

52W High: $19.20
52W Low: $6.34
50D MA: $12.06
200D MA: $12.59
Beta: 0.48
Avg Volume: 535

Get TickerSpark's AI analysis on DNPUF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime